06Dec/23
Enhancing CAR-T Cell Therapy: Modular Cytokine Receptors Boost Anti-Tumor Activity in Solid Tumors
The use of modified chimeric antigen receptor (CAR) T cells (CAR-T) in immunotherapy has significantly improved the survival rates of pediatric patients with relapsed leukemia. However, these therapies are not as effectiveRead More…